TXMD | TherapeuticsMD, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	1.7100 - 1.8400
52 Week Range	1.4300 - 3.47
Beta	1.28
Implied Volatility	546.89%
IV Rank	56.67%
Day's Volume	11,398
Average Volume	17,038
Shares Outstanding	11,532,400
Market Cap	19,720,404
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2007-05-09

Valuation
Profitability
Growth
Health
P/E Ratio	-3.98
Forward P/E Ratio	-0.83
EPS	-0.43
1YR Price Target	1.00
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	1
Country	USA
Website	TXMD

TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates.

TXMD's peers: AQST, EVOK, ADMP, GHSI, ACRX, IRWD, ALKS, EGRX, ANIP, AGRX, TKNO, CYTH, PTPI, LFCR, ORGO, CPIX, PRFX

*Chart delayed

Analyzing fundamentals for TXMD we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is bad and Health is frighteningly weak. For more detailed analysis please see TXMD Fundamentals page.

Watching at TXMD technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on TXMD Technicals page.